ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,918Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 290

$444K Total Retail Price of All Prescriptions

Rank: 20 out of 290

448 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 8,912 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
DIGOXIN 698 648 1 13
WARFARIN SODIUM 546 524 2 7
CARVEDILOL 435 355 3 2
CLOPIDOGREL 370 318 4 11
FUROSEMIDE 297 252 5 4
PLAVIX 275 235 6 12
SPIRONOLACTONE 274 214 7 18
PRAVASTATIN SODIUM 264 240 8 17
AMLODIPINE BESYLATE 256 245 9 6
NITROGLYCERIN PATCH 252 229 10 51
LOSARTAN POTASSIUM 229 203 11 15
METOPROLOL SUCCINATE 215 208 12 8
CHLORTHALIDONE 179 163 13 50
ISOSORBIDE MONONITRATE ER 171 168 14 9
LISINOPRIL 164 135 15 1
AMIODARONE HCL 155 155 16 22
DILTIAZEM 24HR CD 153 130 17 23
LOSARTAN-HYDROCHLOROTHIAZIDE 148 138 18 53
SIMVASTATIN 140 123 19 5
RANEXA 125 96 20 38
NITROSTAT 112 100 21 24
WELCHOL 112 104 21 142
LANOXIN 110 86 23 102
ATORVASTATIN CALCIUM 107 90 24 10
CLONIDINE HCL 107 99 24 57
ATENOLOL 106 84 26 20
SOTALOL 103 101 27 21
COUMADIN 103 88 27 47
ACEBUTOLOL HCL 101 96 29 147
POTASSIUM CHLORIDE 101 82 29 14
LEVOTHYROXINE SODIUM 101 98 29 31
METOPROLOL TARTRATE 90 90 32 3
ALLOPURINOL 86 84 33 66
PACERONE 84 83 34 60
BYSTOLIC 83 83 35 30
DIOVAN 82 69 36 26
CRESTOR 78 75 37 16
OMEPRAZOLE 77 77 38 29
PANTOPRAZOLE SODIUM 75 67 39 45
ATENOLOL-CHLORTHALIDONE 73 70 40 165
VERAPAMIL ER 73 54 40 76
SPIRIVA 72 57 42 105
LOVASTATIN 67 50 43 27
GUANFACINE HCL 64 54 R 44 172
HYDROCODONE-ACETAMINOPHEN 58 48 S3 45 42
METOCLOPRAMIDE HCL 56 56 46 182
DOXYCYCLINE HYCLATE 55 51 47 145
HYDROCHLOROTHIAZIDE 55 49 47 19
EFFIENT 54 45 49 39
JANTOVEN 52 52 50 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.